All articles by

• 

  Oncology R&D: emerging therapies and new challenges​

  The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…

• 

  Overcoming the first hurdles: Navigating early phase challenges for biotechs

  As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges…

• 

  Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay

  Managing chronic myeloid leukemia (CML) can be challenging, especially when it comes to accurately tracking how well patients respond to…

• 

  Cancer therapies for young adults: The need for tailored treatment and diversity

  Cancer, once primarily perceived as a disease of the elderly, is now becoming a major concern for young adults. The…

• 

  Diabesity: Overlapping pathophysiology informs multi-indication treatment

  The striking overlap between type 2 diabetes and obesity reflects the convergence in the underlying pathophysiology of these conditions –…